Australia makes world-first change to blood donation rules
Australia is set to lift its ban on sexually active gay and bisexual men from donating blood and plasma on 14 July, becoming the only country to remove all sexual activity-based restrictions for donating.
The previous rules barred gay and bisexual men, and transgender women who have sex with men, from donating to decrease the risk of HIV transmission.
Lifeblood, the national agency for donation services, estimates the change will allow over 600,000 more people to donate plasma.
While people taking the HIV prevention drug PrEP can donate plasma, they are barred from donating blood. Those with HIV or with a partner with HIV are prevented from donating both blood and plasma.
Lifeblood will implement gender-neutral assessments, asking all potential donors the same questions about sexual activity, regardless of gender or sexuality.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NBC News
30 minutes ago
- NBC News
Trump administration to shut down LGBTQ youth suicide hotline
The Trump administration will shut down the national LGBTQ youth suicide lifeline in 30 days. The Substance Abuse and Mental Health Services Administration announced Tuesday that the 988 Suicide & Crisis Lifeline will no longer utilize its LGBTQ youth services, also known as the 'Press 3 option,' effective July 17. The agency said it will "no longer silo LGB+ youth services" — notably removing the "T" representing the trans community in the acronym — to "focus on serving all help seekers, including those previously served through the Press 3 option." The Press 3 option rolled out as a pilot program in 2022 in a government contract with the Trevor Project, a suicide prevention and crisis intervention organization for LGBTQ people. Those in need of help would call 988 and be given the option to 'press 3' to connect with counselors trained to assist people up to the age of 25. The Trevor Project was initially the sole provider of the youth specialized service, and is now one of seven centers that make up the LGBTQ Youth Subnetwork. It came about under legislation signed by President Donald Trump during his first term that acknowledged disproportionately high suicide rates among LGBTQ youth. SAMHSA insisted that impacted youth can still receive help, but from the general hotline number. 'Everyone who contacts the 988 Lifeline will continue to receive access to skilled, caring, culturally competent crisis counselors who can help with suicidal, substance misuse, or mental health crises, or any other kind of emotional distress. Anyone who calls the Lifeline will continue to receive compassion and help,' the agency said. Trevor Project CEO Jaymes Black called the decision 'devastating,' adding, 'suicide prevention is about people, not politics.' He noted that the program has provided life-saving services to more than 1.3 million LGBTQ young people. 'The administration's decision to remove a bipartisan, evidence-based service that has effectively supported a high-risk group of young people through their darkest moments is incomprehensible. The fact that this news comes to us halfway through Pride Month is callous — as is the administration's choice to remove the 'T' from the acronym 'LGBTQ+' in their announcement. Transgender people can never, and will never, be erased," Black said in a statement. He called upon Congress to reverse the decision — and assured the public that the Trevor Project will continue to help those in crisis. 'I want every LGBTQ+ young person to know that you are worthy, you are loved, and you belong — despite this heartbreaking news. The Trevor Project's crisis counselors are here for you 24/7, just as we always have been, to help you navigate anything you might be feeling right now,' Black said. The Department of Health and Human Services' proposed budget for 2026 eliminated the hotline's youth specialized services program earlier this month. When asked for comment about that proposed cut, Rachel Cauley, a spokesperson for the White House's Office of Management and Budget, told NBC News the proposed budget wouldn't 'grant taxpayer money to a chat service where children are encouraged to embrace radical gender ideology by 'counselors' without consent or knowledge of their parents.' That term, "radical gender ideology," is one that has been adopted by conservatives and the Trump administration to describe transgender people and the trans rights movement, which it considers harmful to children.
The Independent
an hour ago
- The Independent
FDA approves the world's only twice-a-year shot to prevent HIV
The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions – although it's unclear how many in the U.S. and abroad will get access to the powerful new option. While a vaccine to prevent HIV still is needed, some experts say the shot — a drug called lenacapvir — could be the next best thing. It nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take. 'This really has the possibility of ending HIV transmission,' said Greg Millett, public policy director at amfAR, The Foundation for AIDS Research. Condoms help guard against HIV infection if used properly but what's called PrEP — regularly using preventive medicines such as the daily pills or a different shot given every two months — is increasingly important. Lenacapavir's six-month protection makes it the longest-lasting type, an option that could attract people wary of more frequent doctor visits or stigma from daily pills. But upheaval in U.S. healthcare — including cuts to public health agencies and Medicaid — and slashing of American foreign aid to fight HIV are clouding the prospects. Millett said "gaping holes in the system" in the U.S. and globally "are going to make it difficult for us to make sure we not only get lenacapavir into people's bodies but make sure they come back' even as little as twice a year. Gilead's drug already is sold to treat HIV under the brand name Sunlenca. The prevention dose will be sold under a different name, Yeztugo. It's given as two injections under the skin of the abdomen, leaving a small 'depot' of medication to slowly absorb into the body. Gilead didn't immediately announce its price. The drug only prevents HIV transmission – it doesn't block other sexually transmitted diseases. Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide. Only about 400,000 Americans already use some form of PrEP, a fraction of those estimated to benefit. A recent study found states with high use of PrEP saw a decrease in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection they can use without a partner's knowledge or consent. One rigorous study in South Africa and Uganda compared more than 5,300 sexually active young women and teen girls given twice-yearly lenacapavir or the daily pills. There were no HIV infections in those receiving the shot while about 2% in the comparison group caught HIV from infected sex partners. A second study found the twice-yearly shot nearly as effective in gay men and gender-nonconforming people in the U.S. and in several other countries hard-hit by HIV. Ian Haddock of Houston had tried PrEP off and on since 2015 but he jumped at the chance to participate in the lenacapavir study and continues with the twice-yearly shots as part of the research follow-up. 'Now I forget that I'm on PrEP because I don't have to carry around a pill bottle,' said Haddock, who leads the Normal Anomaly Initiative, a nonprofit serving Black LGBTQ+ communities. ' Men, women, gay, straight – it really just kinds of expands the opportunity for prevention,' he added. Just remembering a clinic visit every six months 'is a powerful tool versus constantly having to talk about, like, condoms, constantly making sure you're taking your pill every day.' 'Everyone in every country who's at risk of HIV needs access to PrEP,' added Dr. Gordon Crofoot of Houston, who helped lead the study in men. 'We need to get easier access to PrEP that's highly effective like this is.' ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Reuters
an hour ago
- Reuters
US FDA approves Gilead's twice-yearly injection for HIV prevention
June 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences (GILD.O), opens new tab lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be sold under the brand name Yeztugo. Investors and AIDS activists had been eagerly awaiting the regulatory decision for a drug some have said could help end the 44-year-old HIV epidemic. Lenacapavir, part of a class of drugs known as capsid inhibitors, proved nearly 100% effective at preventing HIV in large trials last year, raising new hope of interrupting transmission of the virus that infects 1.3 million people a year. The academic journal Science dubbed the experimental pre-exposure prophylaxis (PrEP) drug the 2024 Breakthrough of the Year. "This is a milestone moment," said Gilead Chief Executive Daniel O'Day of the approval. "We believe that lenacapavir is the most important tool we have yet to bend the arc of the epidemic and move this epidemic into the history books." Gilead has plans for a rapid launch in the United States as well as a wider rollout of the drug in collaboration with global partners.
